Miocardiopatías en pacientes pediátricos

1. Cox GF, Sleeper LA, Lowe AM, Towbin JA, Colan SD, Orav EJ, et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 2006;118:

1519e31.

2. Centers for Disease Control and Prevention. Other related conditions e cardiomyopathy. Available at http://www.cdc.gov/heartdisease/cardiomyopathy.htm. Accessed December 2, 2016.

3. Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ, et al. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin 2010; 6:401e13. vii.

4. Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348:1639e46.

5. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow JD, Michels VV, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart,

Lung, and Blood Institute workshop. Am J Cardiol 1992;69: 1458e66.

6. Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol 2008;19:104e10.

7. Almomani R, Verhagen JM, Herkert JC, Brosens E, van Spaendonck- Zwarts KY, Asimaki A, et al. Biallelic truncating mutations in ALPK3 cause severe pediatric cardiomyopathy. J Am

Coll Cardiol 2016;67:515e25.

8. Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006;296:1867e76.

9. Sofijanova A, Jordanova O. Pediatric cardiomyopathies. In: J. Milei, G. Ambrosio, editors. doi: 10.5772/55820.

10. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, et al. Report of the 1995 World Health organization/International society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996;93:841e2.

11. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al. Contemporary definitions and classification of the cardiomyopathies: an American heart association scientific

statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology Interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006;113:1807e16.

12. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008;29:270e6. 13. Schwartz ML, Cox GF, Lin AE, Korson MS, Perez-Atayde A, Lacro RV, et al. Clinical approach to genetic cardiomyopathy in children. Circulation 1996;94:2021e38.

14. Cardiomyopathy. Available at https://www.luriechildrens.org/ en-us/care-services/conditions-treatments/cardiomyopathy/ Pages/index.aspx. Accessed December 7, 2016.

15. Pediatric cardiomyopathy. Available at http://www.webmd.com/heart-disease/pediatric-cardiomyopathy. Accessed December 2, 2016.

16. Everitt MD, Sleeper LA, Lu M, Canter CE, Pahl E, Wilkinson JD, et al. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. J Am Coll Cardiol 2014;63:1405e13.

17. Tsuda E, Negishi J, Noritake K, Iwasa T, Abe T. Left ventricular reverse remodeling with infantile dilated cardiomyopathy and pitfalls of carvedilol therapy. J Cardiol 2016;67:147e52.

18. Restrictive cardiomyopathy (RCM). Available at https:// www.cincinnatichildrens.org/service/c/cardiomyopathy/types/restrictive-cardiomyopathy. Accessed December 2, 2016.

19. Jacoby DL, DePasquale EC, McKenna WJ. Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment. CMAJ 2013;185:127e34.

20. Cortez D, Sharma N, Cavanaugh J, Tuozo F, Derk G, Lundberg E, et al. The spatial QRS-T angle outperforms the Italian and Seattle ECG-based criteria for detection of hypertrophic cardiomyopathy in pediatric patients. J Electrocardiol 2015;48: 826e33.

21. Gupta A, Singh Gulati G, Seth S, Sharma S. Cardiac MRI in restrictive cardiomyopathy. Clin Radiol 2012;67:95e105.

22. Keng F. Nuclear imaging of cardiomyopathies. Available at https://humanhealth.iaea.org/HHW/NuclearMedicine/CardiovascularandPulmonary/IAEATrainingCoursesandMeetings/Use_of_nuclear_cardiology_Manila2011/DAY_2_LECTURES/Nuclear_

Imaging_in_Cardiomyopathies.pdf. Accessed December 5, 2016.

23. Thomas DE, Wheeler R, Yousef ZR, Masani ND. The role of echocardiography in guiding management in dilated cardiomyopathy. Eur J Echocardiogr 2009;10:iii15e21.

24. Mogensen J, Arbustini E. Restrictive cardiomyopathy. Curr Opin Cardiol 2009;24:214e20.

25. Losi MA, Nistri S, Galderisi M, Betocchi S, Cecchi F, Olivotto I, et al. Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment. Cardiovasc Ultrasound 2010;8:7.

26. Belloni E, De Cobelli F, Esposito A, Mellone R, Perseghin G, Canu T, et al. MRI of cardiomyopathy. AJR Am J Roentgenol 2008;191:1702e10.

27. O’Donnell DH, Abbara S, Chaithiraphan V, Yared K, Killeen RP, Martos R, et al. Cardiac MR imaging of nonischemic cardiomyopathies: imaging protocols and spectra of appearances.

Radiology 2012;262:403e22.

28. Range FT, Paul M, Scha¨fers KP, Acil T, Kies P, Hermann S, et al. Myocardial perfusion in nonischemic dilated cardiomyopathy with and without atrial fibrillation. J Nucl Med 2009;50:390e6.

29. Matsuo S, Nakae I, Takada M, Murata K, Nakamura Y. Noninvasive identification of myocardial sympathetic and metabolic abnormalities in a patient with restrictive cardiomyopathy e in comparison with perfusion imaging. Ann Nucl Med 2002;16: 569e72.

30. Nakajima K, Bunko H, Taki J, Shimizu M, Muramori A, Hisada K. Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy. Am Heart J 1990;119:1329e37.

31. Yonesaka S, Becker AE. Dilated cardiomyopathy: diagnostic accuracy of endomyocardial biopsy. Br Heart J 1987;58: 156e61.

32. Rapezzi C, Ortolani P, Binetti G, Picchio FM, Magnani B. Idiopathic restrictive cardiomyopathy in the young: report of two cases. Int J Cardiol 1990;29:121e6. 33. Yoshibayashi M, Ono Y, Kohata T, Iwatani H, Nogi S, Kamiya T, et al. Progression to the dilated phase of hypertrophic cardiomyopathy in children. J Cardiol 1990;20:879e87 [Article in Japanese].

34. Murray B, Wagle R, Amat-Alarcon N, Wilkens A, Stephens P, Zackai EH, et al. A family with a complex clinical presentation characterized by arrhythmogenic right ventricular dysplasia/cardiomyopathy and features of branchio-oculo-facial syndrome. Am J Med Genet A 2013;161A:371e6.

35. Cox GF. Diagnostic approaches to pediatric cardiomyopathy of metabolic genetic etiologies and their relation to therapy. Prog Pediatr Cardiol 2007;24:15e25.

36. Rivenes SM, Kearney DL, Smith EO, Towbin JA, Denfield SW. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 2000;102:876e82.

37. Lewis AB, Neustein HB, Takahashi M, Lurie PR. Findings on endomyocardial biopsy in infants and children with dilated cardiomyopathy. Am J Cardiol 1985;55:143e5.

38. Mills KI, Vincent JA, Zuckerman WA, Hoffman TM, Canter CE, Marshall AC, et al. Is endomyocardial biopsy a safe and useful procedure in children with suspected cardiomyopathy? Pediatr Cardiol 2016;37:1200e10.

39. Yang Z, McMahon CJ, Smith LR, Bersola J, Adesina AM, Breinholt JP, et al. Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children. Circulation 2005; 112:1612e7.

40. Gatayama R, Ueno K, Nakamura H, Yanagi S, Ueda H, Yamagishi H, et al. Nemaline myopathy with dilated cardiomyopathy in childhood. Pediatrics 2013;131:e1986e90.

41. Asher CR, Klein AL. Diastolic heart failure: restrictive cardiomyopathy, constrictive pericarditis, and cardiac tamponade: clinical and echocardiographic evaluation. Cardiol Rev 2002; 10:218e29.

42. Regitz-Zagrosek V, Leuchs B, Kru¨lls-Mu¨nch J, Fleck E. Angiotensin-converting enzyme inhibitors and b-blockers in long term treatment of dilated cardiomyopathy. Am Heart J 1995;

129:754e61.

43. Foerster SR, Canter CE. Pediatric heart failure therapy with badrenoceptor antagonists. Pediatr Drug 2008;10:125e34.

44. Askari H, Semizel E, Bostan OM, Cil E. Carvedilol therapy in pediatric patients with dilated cardiomyopathy. Turk J Pediatr 2009;51:22e7.